You are on page 1of 48

Foreword

Dear Doctor,

Essential drugs are those that satisfy the health care needs of the majority of the
population; they should therefore be available at all times in adequate amounts and in
the appropriate dosage forms, and at a price that individuals and the community can
afford.
Careful selection of a limited range of essential medicines results in a higher quality of care,
better management of medicines (including improved quality of prescribed medicines),
and more cost-effective use of health resources
(WHO Expert Committee on the Use of Essential Drugs, 1999).
Many states in India including Karnataka, Kerala, Himachal Pradesh, Delhi, Maharashtra and
Rajasthan have prepared their essential drug lists. The Government of Chhattisgarh also has taken
the initiative to prepare and adopt the Essential Drug List for Chhattisgarh (EDLC). The relevant
Government Orders are enclosed.
The Basic Goals of the ELD Chhattisgarh are:
To ensure the availability and accessibility of essential drugs to all citizens of
Chhattisgarh;
To ensure safety, efficacy and quality of drugs in the public health system;
To encourage and support good prescribing and dispensing practices;

The Process: The Department of Health & Family constituted a committee headed by the Director,
Medical Education with the Director Health Services and the Dean of the Medical College as
members to draw up theEDL Chhattisgarh. In turn, this committee, with the technical assistance of
the State Health Resource Centre, Chhattisgarh set up one day three intensive consultation with
senior medical professionals, the faculty of Raipur Medical College, NGOs active in the health field,
and senior departmental officials. The State Advisory Committee also gave valuable inputs to this
process. Experts in rational drug policy from other states were also invited to this consultation. The
W H O Model List for the year 2015, NELM of 2015, British National Formulary 2009 and National
Drug Formulary 2011 were used as the base papers for this discussion in finalising theEDL
Chhattisgarh.

Selection of Essential medical list


The process by which medicines are selected is critical. An essential medicines list which is
imposed from above will not reflect the need of the users or be accepted by them. It is therefore
very important that the process be consultative and transparent, selection criteria be explicit,
selection of the medicines be linked to evidence-based standard clinical guidelines, clinical
guidelines and the list be divided into levels of care, and are regularly reviewed and updated. A
review of the clinical guidelines and the list should be carried out at least every second year, and
their use and the impact should be monitored. The process of developing a list of essential drug list
is mentioned below.

The Criteria: The principal criteria for the selection of essential drugs for primary, secondary and
tertiary hospital care were based on the WHO guidelines for drawing up an EDL. They include the
following points:
Any drug included must meet the needs of the majority of the population;
Sufficient proven scientific data regarding effectiveness must be available;
Any drug included in the EDL should have substantial safety and benefit/ risk
ratio;
All products must be of acceptable quality, and must be tested on a continuous
basis;
The aim, as a rule, is to include, only products containing single
pharmacologically active ingredients;
Combination products, as an exception, will be included where patient
compliance becomes an important factor or where two pharmacologically active
ingredients are synergistically active in a product;
Products will be listed according to their generic names only;

Where drugs are clinically equally effective, the dugs will be compared on the
following factors:

1. The best cost advantage,


2. The best researched,
3. The best pharmaco kinetic properties,
4. The best patient compliance.

Grading of the Essential Drug List: The EDL Chhattisgarh is published in two parts, first part consist
of list of drugs which are essentially required at primary, secondary and tertiary level of medical
facilities. Second part is drugs which are required at specialty centers and are prescribed by
specialists with extra attention. The main EDL Chhattisgarh covers the needs of all public health
facilities excepting the medical college. It is graded to indicate drugs that shall be supplied to all
health centers and those that are restricted to Primary, secondary and tertiary level medical
facilities.(which includes PHC, community health centers and District Hospitals).

Depending on the specialist and equipment available in each health care institution these facilities
would specify their drug requirements from within this list. The list of drugs for the Medical College
Hospital (tertiary care), was prepared by the faculty of the college and is published as a
supplementary list. Another supplementary list (Universal category) specifies the drugs that would
be made available to the multipurpose health workers both male and female. While grading the list
we have kept in mind the specific demands of Chhattisgarh given the distances and problems in
transport and the fact that referral to higher centers is not easy. The broad principle followed is to
provide as comprehensive a care as possible, made available as peripherally as possible - given
the human resource and infrastructure available at that level. All drug purchase made by the
Government of Chhattisgarh would have to comply with the EDL Chhattisgarh.
Amendment of EDL/ Adding a New Product on EDL Chhattisgarh: We recognize that a good drug
policy requires to EDL Chhattisgarh dynamic and updated periodically. We welcome suggestions
towards this. Requests for products to be included on the EDL Chhattisgarh must conform to the
above criteria and must be supported by evidence-based data and appropriate references on its
advantages and benefits over existing products. A format for such requests has been given as
been appended.
The Department of Health and Family Welfare will be appointing a Committee to monitor the
implementation of the EDL Chhattisgarh and make periodic revisions of the list. An essential drug
formulary, and a graded standard treatment protocol as well as mechanisms to train various
categories of staff and promote the use of the list would be in place soon. Other supporting systems
to ensure safe and adequate essential drug supply to every citizen of Chhattisgarh are in our plans.
I hereby express my sincere thanks to all those experts, the medical community of Chhattisgarh
and the concerned NGO representatives whose valid contributions paved way to the EDL
Chhattisgarh and its publication. I hope the medical community of the state will welcome and
nourish this move as this is the threshold point towards a comprehensive and rational drug policy
for the state.

Sincerely Yours,

Vikas Sheel
Secretary to Government of Chhattisgarh
Department of Health & Family Welfare.
Acknowledgements

Even small efforts raise large debts. For the finalisation of the Essential Drug List of
Chhattisgarh, we are indebted to a number of individuals and organisations. The committee
appointed by the Department of Health & Family Welfare led by the Dr Shashank Gupta,
HOD, Medicine JNMCH Medical College Hospital Raipur. Dr. S K Shandilya came up with
the idea of holding a workshop for finalizing the Essential Drug List and charting out the
broad contours of the State Drug Policy. Dr. A K Chandrakar, Dean, Jawaharlal Nehru
Memorial Medical College, Raipur not only made valuable contributions to the consultation
but also enthused the senior faculty of this primer institution to attend and contribute to the
deliberations in meetings. Director, Health Services, ensured the participation of his colleagues
and has supported this process since its inception.

Dr Rajesh Rishikar, Dr G P Soni, Dr Smt S Phuljhele, Dr K K Sahare, Dr S Phuljhele, Dr P


Beck, Dr R R Sahni, Dr Pratibha Jain Shah, Dr Nalini Mishra, Dr rajesh Sharma, Dr J P
Meshram, Dr Prashant Srivastav, Dr B K Das, Dr S P Kujur, Dr S A Khan, Dr V B Verma, Dr
S Gupta, attended the sessions.

The State Advisory Committee has helped in the broadening of the mandate of the changes
being undertaken in the health sector in Chhattisgarh and provided the much-needed
perspective for this effort.

Narayan Tripathi, Fidius Kerketta and Dr Prabir Chatterjee from State Health Resource
Centre undertook the logistics and co-ordination of the workshop and courteously
accommodated every demand made of them during and after the workshop.

Lastly, much of the efforts towards community basing of health services in Chhattisgarh
would not have been possible without the strong endorsement, conviction and belief of Dr
Ayyaz F Tamboli and Avinash Chamapavat IAS who were MD NHM when this work was in
progress.

R Prasanna
Director Health Services,
Department of Health & Family Welfare
ESSENTIAL DRUGS LIST PART I
CONTENTS
PART A
1. ANAESTHETICS
2. ANALGESICS, ANTIPYRETICS, NONSTEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIDS), MEDICINES
USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS USED IN RHEUMATOLD DISORDERS
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
5. ANTICONVULSANTS / ANTIEPILEPTICS
6. ANTI INFECTIVE DRUGS
7. ANTIMIGRAINE MEDICINES
8. ANTINEOPLASTIC IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
9. ANTIPARKINSONS MEDICINE
10. MEDICINES AFFECTING THE BLOOD
11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
12. CARDIOVASCULAR MEDICINES
14. DERMATOLOGICAL MEDICINES (topical)
15. DIAGNOSTIC AGENTS (enlisted in section of Surgical and suture list)
16. PERITONEAL DIALYSIS SOLUTION restricted to tertiary care center where peritoneal dialysis is undertaken
17. DISINFECTANTS AND ANTISEPTICS
18. DIURETICS
19. EAR, NOSE AND THROAT PREPARATIONS
20. GASTROINTESTINAL MEDICINES
21. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
22. IMMUNOLOGICALS
23. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
24. SPECIFIC MEDICINES FOR NEONATAL CARE
25. OPHTHALMOLOGICAL PREPARATIONS
26. OXYTOCICS AND ANTIOXYTOCICS
27. PSYCHOTHERAPEUTIC MEDICINES
28. MEDICINES ACTING ON THE RESPIRATORY TRACT
29. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
30. VITAMINS AND MINERALS
PART-B
SURGICAL, DIAGNOSTIC AGENTS AND SUTURE LIST
1. ABSORBABLE SUTURES
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
3. POLYGLECAPRON SUTURES
4. POLYDIOXANONE SUTURES
APPENDIX
1. Format to Amend the Essential Drug List for Chhattisgarh
2. Adverse Drug Reaction Reporting Form http://ipc.nic.in http://cdsco.nic.in/pharmacovigilance.htm
3. List of Participants
4. Universal Category List
5. Primary Category List
6. Secondary Category List
7. Specialist Category List
ESSENTIAL DRUG LIST -2016
1. ANAESTHETICS
1.1 General anaesthetics and oxygen
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Halothane Inhalation S 250ml Bottle D253
50 mg/ml in 2ml Vial S 2ml Vial D297
Ketamine hydrochloride Injection
50 mg/ml in 10ml 10ml Vial D298
Vial
Nitrous oxide Inhalation S Cylinder D372
Oxygen Inhalation P Cylinder D392
Thiopentone sodium Injection 0.5 g S 50 ampoules D503
1.0 g D504
Isoflurane Inhalation (Vaporiser) T 100 ml Bottle D286
Sevoflurane Inhalation (Vaporiser) T 250ml PEN Bottle D471
Propofol Injection 1% S 20ml vial D439
1.2 Local anaesthetics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bupivacaine hydrochloride Injection 0.25% in vial P 20ml Vial D80
0.5% in vial D81
Injection for Spinal 0.5% in 4-ml P 4ml Ampoule D82
Anaesthesia ampoule to be mixed
with 7.5% glucose
solution
Lidocaine hydrochloride Injection 1% P 30ml vial D307
2% 30ml vial D308
Injection for Spinal 5% to be mixed with 2ml ampoule D309
Anaesthesia 7.5% glucose
solution
Jelly (Topical) 2% S 30gm tube D310
Viscous Solution (Topical) 4% P 30ml D311

Lidocaine hydrochloride + Injection 1%+ epinephrine S 30ml vial D313


Epinephrine (adrenaline) 1:200 000
Dental Cartridge 2% + epinephrine 50ml vial D314
1:80 000 in 2.2ml
cartridge
Glycopyrrolate USP Injection 0.2mg/ml S 1ml ampoule D248
1.3 Preoperative medication and sedation for short-term procedures
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atropine Sulphate Tablet 1mg S 10 x 10 D55
Injection 0.6 mg/ml 2ml ampoule D56
Diazepam Injection 5 mg/ml P 2ml ampoule D164
Tablet (Scored) 5 mg 10 x 10 D165
Morphine (Sulphate or Injection 10 mg S 1ml ampoule D358
hydrochloride)
Promethazine Hydrochloride Syrup 5 mg/5 ml P 60ml bottle D437

Fentanyl Citrate Injection 0.05mg/ml T 2ml ampoule D217


Midazolam Injection 1mg/ml T 5ml vial D350
2. Analgesics, Antipyretics, Nonsteroidal Anti-inflammatory Medicines (NSAIDs),
Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders
2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIDs)
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acetyl Salicylic Acid (ASA) Tablet (Enteric Coated) 75 mg P 10 x 10 D2
150 mg 10 x 10 D3
325 mg 10 x 10 D4
Ibuprofen Tablet 200 mg P 10 x 10 D271
400 mg 10 x 10 D272
Suspension 100mg/5ml 60ml bottle D273
Paracetamol Tablet 500 mg U 10 x 10 D395
Syrup 125 mg/5ml 60ml bottle D396
Suppository 250mg P 5 suppository D397
Paracetamol Injection IM S 2ml D395A
-
Diclofenac sodium Tablet 50mg P 10 x 10 D168
Tablet 50mg 10 x 10 D608
Injection 25mg/ml PG 3ml ampoule D170
surfactant free
Gel 1% w/v 25 gm tube D171
Suppository 50mg S -
5suppository D607
Ketorolac Tablet 10mg S 10x10 D675
-
Injection 15mg/ml 1ml D676
Paracetamol suppository 80 mg P 5 suppository D711
Aceclofenac Tablet 100mg T(R) ND21
2.2 Opioid analgesics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Morphine (Sulphate or Injection 10 mg/ml T 1ml ampoule D358
hydrochloride)
Pentazocine Injection 30mg/ml S 1ml ampoule D398
Tramadol Injection 50mg/ml S 5x1ml D753
Tablet 50mg 10x10 D754
Buprenorphine Patch 5mcg T ND13
2.3 Medicines used to treat gout
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Allopurinol Tablet 100mg T 10 x 10 D16
2.4 Disease modifying Agents used in Rheumatoid Disorders (DMARDs)
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydroxy Chloroquine (as Tablet 150 mg (base) S 10 x 10 D266
phosphate or sulphate)
Methotrexate Sodium Tablet 2.5mg T 10 x 10 D335
7.5 mg 10x10 D685
Sulfasalazine Tablet 500 mg S 10 x 10 D493
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Chlorpheniramine Injection 10 mg/ml P 1ml ampoule D115
Tablet 4 mg 10 x 10 D116

Oral Solution Syrup 2mg/5ml D117

Pheniramine Injection 2ml P ampoule D115A


Dexamethasone Injection 4 mg/ml P 2ml ampoule D157

Epinephrine Hydrochloride Injection 1 mg/ml U 1ml ampoule D199


(Adrenaline)
Hydrocortisone sodium Powder for Injection 100 mg P Vial D261
succinate
Prednisolone Tablet 10mg P 10 x 10 D427
20mg 10 x 10 D428
Liquid 5mg/5ml 120ml bottle D429
Methylprednisolone Tablet 4 mg T D689
Injection 40mg/ml T Vial D336
Cinnarzine Tablet 25mg T 10 x 10 D121
Syrup 5mg/ml P D583
Fluticasone Nasal spray 120 metered dose
S D642
Hydroxyzine Syrup 10mg/5ml S D662
Hydroxyzine Injection 25mg S 10 x 10 D662A
Levo-Cetrizine Tablet 5 mg P D683
Cetrizine Tablet 5 mg P D683A
Deflazacort Tablet 6mg T(R) ND25
Budesonide Respules T ND8
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
4.1 Non Specific
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Active Charcoal Powder P D5

4.2 Specific
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atropine Sulphate Injection 0.6 mg/ml P 2ml ampoule D56
Calcium gluconate Injection 100 mg/ml P 10ml ampoule D84
Pralidoxime Injection 25mg/ml P 20ml Vial D426
Neostigmine Metilsulfate Injection 500 micrograms S 1ml ampoule D364
Disulfiram Tablet 250mg T D609
500mg T D610
Prazocin Tablet 1mg S D717
Tablet 2mg S D718
Deferasirox Injection 500mg T D602
Tablet 500mg T D603

5. ANTICONVULSANTS/ANTIEPILEPTICS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Carbamazepine Tablet (Control Release) 200 mg S 10 x 10 D86

400 mg 10 x 10 D87

Syrup 20 mg/ml 100ml bottle D88


Diazepam Injection 5 mg/ml S 2ml ampoule D164
Tablet (Scored) 5 mg P 10 x 10 D165
Suppository 5mg 1x5 D166
Suspension 2mg/5ml 60ml Bottle D167
Magnesium sulphate Injection 500 mg/ml U 10ml ampoule D321
Phenobarbitone Tablet 30mg P 10 x 10 D402
60mg 10 x 10 D403
Syrup 20mg/5ml P 60ml bottle D404
Injection 200mg/ml T 1ml ampoule D405
Phenytoin Sodium Tablet 100 mg P 10 x 10 D408
Injection 50 mg/ml 5ml vial D409
Valproic acid (Sodium salt) Tablet (Control Release) 200mg S 10 x 10 D514
Valproic acid (Sodium salt) Tablet (Control Release) S

500mg 10 x 10 D515

Liquid Oral Solution 200mg/5ml 100ml bottle D516

Injection 100mg/ml T 5ml D760

Midazolam Injection 1mg/ml T 5ml vial D350


Lorazepam Tablet 1mg T 10 x 10 D318
Injection 4mg 2ml ampoule D319
Clobazam Tablet 10mg T ND4
Levetiracetam Tablet 500mg T ND5
Pregabalin Tablet 75mg T(R) ND27
6. ANTI INFECTIVE DRUGS
6.1 Anti-helminthes
6.1.1 Intestinal anthelminthics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Albendazole Tablet (Chewable) 400 mg U Single dose pack D12
Suspension 200mg/5ml 10ml bottle D13
Mebendazole Tablet 100mg S 6 tab x 10 D324
Suspension 100mg/5ml 30ml bottle D325
6.1.2 Anti-filarials
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Diethyl carbamazine citrate Tablet 50mg P 10 x 10 D174
100 mg 10 x 10 D175
Ivermectin Tablet (Scored) 6mg T 1 tab x 10 D296
6.2.1 Beta Lactam medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Amoxicillin anhydrous Tablet or Capsule 250 mg P 10 x 10 D28
500 mg 10 x 10 D29
Powder for Oral 125 mg/5 ml 30ml bottle D30
Suspension
Tablet 125mg 10x10 D560
Ampicillin Sodium Powder for Injection 1gm P Vial D41
Benzathine benzyl penicillin Powder for Injection 1.44 g P 5ml vial D66
benzylpenicillin (=2.4
million IU)
Benzyl penicillin(sodium or Powder for Injection 600 mg (= 1 million P Vial D71
potassium salt) IU)
Cloxacillin Sodium Capsule 500 mg S 10 x 10 D133
Powder for Oral Solution 125 mg/5 ml 30ml bottle D135

Cefalexin Tablet or Capsule 250mg S 10 x 10 D95


500mg 10 x 10 D96
Oral Solution 125mg/5ml S 30ml bottle D97

250mg/5ml 30ml bottle D98

Ceftriaxone Sodium Powder for Injection 250mg T Vial D104


1gm S 30ml Vial D105
Ceftazidime Injection 250mg T Vial D102
1gm Vial D103
Imipenem Monohydrate + Powder for Injection 250mg + 250mg T Vial D274
Cilastatin Sodium
Amoxicillin + Clavulanic acid Suspension 125mg + 31.25mg S 30ml bottle D31
(156mg)/5ml
250mg + 62.5mg S 30ml bottle D32
(312mg)/5ml
Injection 250mg +50mg S Vial D33
(300mg)
500mg + 100mg Vial D34
(600mg)
1gm + 200mg (1.2 Vial D35
gm)
Tablet 250mg + 125mg S 6 tab x 10 D36
(375mg)
500mg + 125mg S 6 tab x 10 D37
(625mg)
Cefpodoxime Syrup 50mg/5ml T 30ml D581
Tablet 200 mg 10x10 D582
6.2.2 Other antibacterial
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ciprofloxacin Hydrochloride Tablet 250 mg P 10 x 10 D122

500 mg 10 x 10 D123

Infusion 2mg/ml S 100ml D124

Doxycycline Hydrochloride Capsule 100 mg P 10 x 10 D192


Erythromycin Stearate Tablet or Capsule 250 mg S 10 x 10 D202
Erythromycin Stearate Tablet or Capsule S
500mg 10 x 10 D203
Powder for Oral 125 mg/5ml 60ml bottle D204
Suspension
Azithromycin Tablet 250 mg P 6 tab x 10 D60
500mg 6 tab x10 D61
Syrup 100 mg/5ml S 15ml bottle D62
Gentamicin Sulphate Injection 10 mg/ml P 2-ml vial D242
40 mg/ml P 2-ml vial D243
Metronidazole Tablet 200mg P 10 x 10 D344
Infusion/ Injection 500 mg 100ml bottle D346
Metronidazole Benzoate Oral Suspension 200 mg/5 ml P 60ml bottle D347
Sulphamethoxazole + Tablet 200 mg + 40 mg P 10 x 10 D490
Trimethoprim
400 mg + 80 mg 10 x 10 D491

Oral Suspension 200 mg + 40 mg/5 60ml bottle D492


ml
Cefadroxyl Tablet 250mg T 10 x10 D92
Cefadroxyl Tablet 500mg T 10 x 10 D93
Cefadroxyl Syrup 125mg/5ml T 30ml bottle D94
Amikacin Injection 100mg/2ml T Vial D19
Amikacin Injection 250mg/2ml T Vial D20
Amikacin Injection 500mg/2ml T Vial D21
Vancomycin Hydrochloride Powder for Injection 250mg T Vial D517
Vancomycin Hydrochloride Powder for Injection 500mg T Vial D518
Cefixime Capsule 100mg T 10 x 10 D99
Cefixime Capsule 200mg T 10 x 10 D100
Cefixime Dry Syrup 50mg/5ml T 30ml bottle D101
Meropenem Injection 1gm T 5mlVial D864A
500mg 5mlVial D684
Netilmicin Injection 10mg T 5mlVial D701
Netilmicin Injection 50mg T 5mlVial D702
Piperacillin+Tazobactam Injection 4.5gm T ND9
colistin Powder for injection 1mu/vial T ND10
6.2.3 Antileprosy medicines (Antileprosy and antitubercular drugs should be provided as per national programme)

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Clofazimine Capsule 50 mg P D128
100 mg 10 x 10 D129
Dapsone Tablet 25 mg P 10 x 10 D147
50 mg 10 x 10 D148
100 mg 10 x 10 D149
Rifampicin Tablet or Capsule 150 mg P 10 x 10 D456
450 mg 10 x 10 D457
600 mg 10 x 10 D458
Ofloxacin Tablet 200mg T 10 x 10 D378
400mg 10 x 10 D379
6.2.4 Antituberculosis medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ethambutol Hydrochloride Tablet 400 mg P 10 x 10 D629
200 mg 10 x 10 D630
800 mg 10 x 10 D205
Isoniazid Tablet 100mg P 10 x 10 D287
300 mg 10 x 10 D288
Pyrazinamide Tablet 500 mg P 10 x 10 D445
750 mg 10 x 10 D446
Rifampicin Tablet or Capsule 150 mg P 10 x 10 D456
450 mg 10 x 10 D457
600 mg 10 x 10 D458
Streptomycin Sulphate Powder for Injection 1g P Vial D485
Cycloserine Tablet 250mg P 10 x 10 D596
Ethionamide Tablet 250mg S 10 x 10 D634
Kanamycin Tablet 500mg S 10 x 10 D673
1000mg 10 x 10 D674
Linezolid 300ml bottle 2mg/ml T ND16
Levofloxacin Tablet 500mg T(R) ND17
6.3 Antifungal medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Amphotericin B lipholised Powder for Injection 50 mg T Vial D38
Fluconazole Capsule 150 mg P Single dose pack/ 10 x D225
10
200 mg D226
Injection 2 mg/ml P Vial D227
Oral Suspension 50 mg/5-ml P D228
Nystatin Oral Solution 50mg/5ml (100000 T D376
IU/ml)
Lozenge 100000 IU D377
Povidone Iodine Vaginal Passaries 200mg S 10 passaries D425
Clotrimazole Ear Drops 1% W/V S 10ml D130
Clotrimazole S
Mouth Paint 1% W/V D131
Cream 2% W/W P 15gm tube D132
Benzoic acid compound Ointment (6%+ 3% ) T 15gm tube D67
(Benzoic acid + Salicylic acid)

Clotrimazole+ Steroid Ointment 1%w/w+0.025%w/w P 10gTube D591

Ear Drops 1%w/v+2%w/v D592


Clindamycin+clotrimazole Vaginal Tablet 100mg+100mg P 1x6 tab D587
Metronidazole Vaginal gel Vaginal Gel 0.75% P 5gm D690
caspofungin Powder for injection 50mg,70mg T ND11
6.4 Antiviral medicines
6.4.1 Antiherpes medicines

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acyclovir Tablet 200 mg S 10 x 10 D6
Oral Solution 200mg/5ml 60ml bottle D7
Ophthalmic Ointment 0.03 5gm tube D9
Powder for Injection 250 mg 10ml Vial D10
Tablet 800mg 10x10 D559
6.4.2 Anti retrovirals Medicine
6.4.2.1 Nucleoside reverse transcriptase inhibitors-T ART (to be provided by NACO)

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Zidovudine Capsule 100 mg S 10 x 10 D536
250 mg 10 x 10 D537
Tablet 300 mg 10 x 10 D538
Oral Liquid 50 mg/5 ml 100ml bottle D539
IV or Infusion Injection 10mg/ml 20ml Vial D540
Stavudin+Lamuvidin Tablet 30mg+150mg T 10x10 D737
Zidovudine +Limuvidin+ Tablet 300mg+150mg+200 S 10x10 D762
Nevirapine mg
6.4.3 Other antivirals
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Oseltamivir Capsule 30 mg T 10 x 10 D388
Capsule 45 mg 10 x 10 D389
Capsule 75 mg 10 x10 D390
Syrup 100ml bottle 10x10 D707
Dry Powder for Oral 12 mg/ml 75ml bottle D391
Suspension
Nevirapine Tablet 200mg T 10 x 10 D363
Oral Suspension 50mg/5ml 100ml D364

6.5 Antiprotozaol Medicines


6.5.1 Antiamoebic and antigiardiasis medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Metronidazole Tablet 200mg P 10 x 10 D344
400mg U 10 x10 D345
Injection 500 mg P 100ml vial D346
Oral Suspension 200 mg/5 ml P 60ml bottle D347
Tinidazole Tablet 500mg S 10 x 10 D507
1gm 10 x10 D508
Nitazoxamide Syrup 100mg/5ml P 30ml D704
6.5.2 Antileishmaniasis medicines
6.5.3 Antimalarial medicines (as per National Programme Guideline)
6.5.3.1 For curative treatment
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Artemether Injection 80 mg/ml S 1ml ampoule D47
Artesunate Injection 60mg P 2ml ampoule D50
Chloroquine (as hydrochloride, Injection 40 mg/ml P 5ml ampoule D112
phosphate or sulphate)

Tablet 150 mg base U 10 x 10 D113

Syrup 50 mg /5ml 60ml bottle D114

Primaquine Tablet 7.5 mg U 10 x 10 D432


Diphosphate/Phasphate
2.5 mg 10 x 10 D433
Quinine (bisulphate or Tablet 300 mg P 10 x 10 D448
sulphate)
Oral Solution 150mg/5ml 60ml Bottle D449

Injection 300 mg/ml 2ml ampoule D450


ACT combi Blister Pack Tablet (Pink Colour) 0-1 year U Combi pack for full D555
(AS:25mg,SP:125m course (3 days)
g+6.25mg)
ACT combi Blister Pack U

Tablet (Yellow Colour) 2-4 year Combi pack for full D558
(AS:50mg,SP:500m course (3 days)
g+25mg)
Tablet(Green Colour) 5-8 year Combi pack for full D554
(AS:100mg,SP:750 course (3 days)
mg+37.5mg)
Tablet (Red Colour) 9-14 year Combi pack for full D556
(AS:150mg,SP:500 course (3 days)
mg+25mg)
Tablet (White Colour) 15 year & above Combi pack for full D557
(AS:100mg,SP:750 course (3 days)
mg+37.5mg)
Artether Injection 150mg P 2 ml x 3 D562
6.6. Insect repellant
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Diethyltoluamide Cutaneous Solution 0.5 P D176
0.75 D177
Synthetic pyrethroid WP As per NVBDCP U D496
Supply
DDT Powder As per NVBDCP U D151
Supply
Deltamethrin Solution 2.50% U D153
7. ANTIMIGRAINE MEDICINES
7.1 For acute attack
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acetyl Salicylic Acid (ASA) Tablet (Enteric Coated) 325 mg P 10 x 10 D4
Paracetamol Tablet 500 mg P 10 x10 D395
Clonidine injection 150mg/ml T ND15
7.2 For prophylaxis
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Propranolol Tablet 10 mg S 10 x10 D440
40 mg 10 x 10 D441
8. ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bortezomib IP Injection 2 mg T(R) Vial D571
Carboplatin IP Injection 150 mg T(R) Vial D579
Carboplatin IP Injection 450mg T(R) Vial D580
Cisplatin Injection 10mg/10ml T(R) Vial D127
Cyclophosphamide Injection 200mg T(R) 30ml vial D144
Cyclophosphamide Injection 500mg T(R) Vial D595
Docitaxel IP Injection 20 mg with Solvent T(R) Vial D612
Docitaxel IP Injection 80 mg with Solvent T(R) Vial D613
Doxorubicin Injection 10mg/5ml T(R) 5ml Vial D191
Florouracil Injection 250mg T(R) 5ml ampoule D224
Hydroxyurea Capsule 500mg T(R) 10 x 10 D268
Methotrexate Tab./Injection 5mg T(R) 10 D685
Methotrexate Injection 10mg T(R) Vial D686
Methotrexate IP (preservative free) Injection 15 mg T(R) Vial D688
Erythropoietin IP Injection 10000 units T(R) Vial D624
Erythropoietin IP Injection 40000 units T(R) Vial D624A
Tamoxifen Injection 20mg T(R) Vial D742
Tamoxifen Injection 10mg T(R) Vial D742A
Oxaliplatin IP Injection 100 mg T(R) Vial D708
Oxaliplatin IP Injection 50 mg T(R) Vial D709
Bicalutamide Tablet 50 mg T(R) 10 D568
Bleomycin Injection 15mg T(R) Vial D79
Capecitabine Capsule 500 mg T(R) 10 D578
Chlorambucil Capsule 5mg T(R) 10 tablet packs/10 x 10D107
D actinomycin Injection 0.5mg T(R) Vial D146
Daunorubicin IP Injection 20 mg T(R) Vial D600
Etoposide Capsule 100mg T(R) 4cap. Pack/4cap.x 10 D213
Etoposide Injection 100mg/5ml T(R) 5ml Vial D214
Ifosphamide IP Injection 1gm T(R) Vial D666
L.Asparaginase IP Injection 10000 units T(R) Vial D678
Mercaptopurine Tablet 50mg T(R) 10 x 10 D332
Paclitaxel IP Injection 260 mg with solvent T(R) Vial D710
Procarbazine Capsule 50mg T(R) 10 x 10 D434
Rituximab Injection 10mg/ml T(R) Vial D729
Temozolomide Capsule 100mg T(R) 10 D745
Temozolomide Capsule 250mg T(R) 10 D746
Temozolomide Injection 20mg T(R) 10mg D747
Thalidomide Tablet 100 mg T(R) 10 D748
Trastuzumeb Injection 440 mg T(R) Vial D756
Vinblastine Injection 10mg T(R) Vial D522
Vincristine Injection 1 mg T(R) Vial D523
Cytarabine Injection 500mg T(R) 5ml Vial D145
Cytarabine Injection 100mg T(R) 5ml Vial
Granisetron IP Tablet 1mg T(R) 10 D656
Granisetron IP Injection 3mg T(R) Ampoule D657
Idarubicin IP Injection 10 mg T(R) Vial D665
Irinotecan IP Injection 100 mg T(R) Vial D671
Leucovarin IP Injection 50 mg T(R) Vial D682
Nenotaxel IP Injection 100 mg T(R) Vial D698
Nenotaxel IP Injection 300mg T(R) Vial D699
Pemetrixate IP Injection 500 mg T(R) Vial D712
Pemetrixate IP Injection 100mg T(R) Vial D713
Busulfan Capsule 2mg T(R) 10 x 10 D83
Dacarbazine Injection 200mg T(R) ND7
Dacarbazine Injection 400mg T(R)
Arsenic trioxide Injection 1mg/ml T(R) ND31
Calcium folinate Tab 15mg T(R) ND32
Calcium folinate Injection 3mg/ml T(R) ND32A
Mesna Injection 100mg/ml T(R) ND33
9. ANTIPARKINSONS MEDICINE
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Trihexyphenidyl Hydrochloride Tablet 2 mg S 10 x 10 D511

Levodopa + Carbidopa Tablet 100 mg + 10 mg S 10 x 10 D301


Tablet (Control Release) 250 mg + 25 mg 10 x 10 D302
10. MEDICINES AFFECTING THE BLOOD

10.1 Antianaemia medicines


Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ferrous Fumarate Drop 5mg/ml U 10 x 10 (Enteric Coated D218
)
Ferrous Sulphate Tablet 100 mg elemental U 10 x 10 D219
iron
Oral Solution equivalent to 25 mg D220
iron
Ferrous Sulphate + Folic Acid Tablet Dried Ferrous U 10 x 10 D221SU
Sulphate IP eq. to
Ferrous Iron 100 mg
& Folic Acid IP 0.5
mg (Red Colour)

Dried Ferrous 10 x 10 D221


Sulphate IP eq. to
Ferrous Iron 100 mg
& Folic Acid IP 0.5
mg (Blue Colour)

equivalent to 20 mg 10 x 10 D222
iron + 0.1mg folic
acid
Syrup equivalent to 20 mg U 10 x 10 D223
Iron + 0.1mg Folic
acid per 1ml in bottle

Folic Acid Tablet 1mg P D232


5mg D233
400mcg
Injection 1 mg 1ml ampoule D234
Hydroxocobalamin Injection 1 mg S D265
Iron Sucrose Injection 50mg S D284
100mg 10 x 10 D285
Hydroxyurea Capsule 500mg S D268
250mg D661
10.2 Medicines affecting coagulation

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Heparin Sodium Injection 1000 IU/ml S 1ml ampoule D254
5000 IU/ml 1ml ampoule D255
20000 IU/ml 1ml ampoule D256
Phytomenadione Injection 10 mg/ml S 5ml ampoule D410
Tablet 10 mg D411
Protamine Sulphate Injection 10 mg/ml S 5ml ampoule D444
Warfarin Sodium Tablet (Score) 1 mg S 10 x 10 D530
5 mg 10 x 10 D531
Vitamin K Injection 1mg/ml T 1ml ampoule D528
Vitamin K1 Injection 1mg/ml T (R) 1ml ampoule D529
Streptokinase Injection 15,00,000 IU T Vial D484
11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
11.1 Plasma substitutes
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydroxyethyl Starch Injection 6% S 500ml D267
Tranexamic Acid Tablet 500mg T 10 x 10 D509
Injection 500mg/5ml 5ml ampoule D510
11.2 Plasma fractions for specific use T
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Albumin Injection 20% in 50ml T D14
20% in 100ml D15
Cryoprecipitate Injection T D142
Factor IX Complex Injection Dried T D215
(Coagulation factors II,VII,IX X)

Factor VIII Concentrate Injection Dried T D216


Platelet Rich Plasma Injection T D415
12. CARDIOVASCULAR MEDICINES
12.1 Antianginal medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Isosorbide Dinitrate Tablet (Sublingual) 5 mg S 10 x 10 D289
10 mg P 10 x 10 D290
Isosorbide Monoinitrate Tablet (Sublingual) 5 mg T 10 x 10 D291
10 mg 10 x 10 D292
Acetyl Salicylic Acid (ASA) Tablet (Enteric Coated) 75 mg P 10 x 10 D2
150 mg 10 x 10 D3
Verapamil Hydrochloride Tablet 40 mg T 10 x 10 D520
Glyceryl Trinitrate Injection 25mg T 5ml ampoule D371
Tablet 2.6mg S 10x10 D654
6.4mg 10x10 D655
Clopidogrel Tablet 75mg T 10x10 D589
12.2 Antiarrhythmic medicines

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atenolol Tablet 50 mg P 14 x 10 D52
Digoxin Tablet 250 mcg S 10 x 10 D178
Oral Solution 50 mcg/ml 30ml D179
Injection 250 mcg/ml 2ml ampoule D180
Lidocaine Hydrochloride Injection 20 mg/ml S 5ml ampoule D312
(preservative free)
Verapamil Hydrochloride Tablet 40 mg T 10 x 10 D520
Injection 2.5 mg/ml S 2ml ampoule D521
Amiodarone Tablet 200mg T 10 x 10 D23
Injection 150mg 3ml vial D24
Diltiazem Tablet 30mg T 10 x 10 D181
Injection 30mg Vial D182
Adenosine Injection 3mg/ml T 2ml ampoule D11
12.3 Antihypertensive medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atenolol Tablet 50 mg P 14 x 10 D52
25 mg 14 x 10 D53
Enalapril Tablet (Scored) 2.5 mg S 10 x 10 D197
5 mg 10 x 10 D198
Hydrochlorothiazide Tablet (Scored) 25 mg P 10 x 10 D259
Tablet 50 mg 10 x 10 D260
Hydrochlorothiazide Tablet 12.5mg P 10 x 10 D260A
Methyldopa Tablet (Film Coated) 250 mg S 10 x 10 D337
Nifedipine Capsule 5 mg P 10 x 10 D366
Tablet (Sustained 10 mg 10 x 10 D367
Released)
20 mg 10 x 10 D368

Mephenteramine Injection 30mg/ml T 10ml Vial D331


Nor adrenaline Injection 4mg/2ml S 2ml ampoule D373
Metoprolol Tablet 25mg S 10 x 10 D341
50mg 10 x 10 D342
Injection 1mg/ml T 5ml ampoule D343
Labetalol Tablet 100mg S 10 x 10 D299
Injection 10mg/ml 20ml vial D300
Telmisartan Tablet 20mg S 10x10 D743
40mg 10x10 D744
S-Amlodipine Tablet 2.5mg T 10x10 D730
5mg 10x10 D731
Amlodipine Tablet 5mg T 10x10 D731A
Sodium Nitropruside Injection 5ml T 5mlVial D735
Olmesartan Tablet 20mg T(R) ND26
12.4 Medicines used in heart failure
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Enalapril Tablet (Scored) 2.5 mg S 10 x 10 D197
5 mg 10 x 10 D198
Digoxin Tablet 250 mcg S 10 x 10 D178
Oral Solution 50 mcg/ml 30ml D179
Injection 250 mcg/ml 2ml ampoule D180
Dopamine Hydrochloride Injection 40 mg S 5ml vial D190
Hydrochlorothiazide Tablet (Scored) 25 mg P 10 x 10 D259
Tablet 50 mg 10 x 10 D260
Dobutamine Injection 50 mg /ml T 5ml ampoule D187
Furosemide Tablet 40mg P 10 x 10 D239
Injection 10 mg/ml 2ml ampoule D240
Ramipril Tablet 2.5 mg S 10x10 D726
5mg 10x10 D727
Carvedilol Tablet 3.125mg T(R) ND23
12.5 Drugs used in Eclampsia
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Methyldopa Tablet 250 mg/500mg P 10 x 10 D337
Magnesium Sulphate Injection 500 mg/ml U 10ml ampoule D321
12.6 Lipid Lowering Agent
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atorvastatin Tablet 10 mg S 10x10 D563
20mg 10x10 D564
40mg 10x10 D564A
Fenofibrate Tablet 300mg T 10x10 D635
14. DERMATOLOGICAL MEDICINES (topical)
14.1 Antifungal medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Miconazole Nitrate Ointment or Cream 2% P 15gm tube D349

14.2 Anti-infective medicines


Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acyclovir Cream 5% S 15gm tube D8
Framycetin Sulphate Cream 0.50% U 5gm or 15gm tube D235
Povidone Iodine Solution 5% U 500ml bottle D422
Ointment 5% 15gm tube D423
Neomycin Sulphate + Ointment 5 mg + 500 IU/gm P 5gm or 15gm tube D360
Bacitracin Zinc
Silver Sulfadiazine Cream 1% w/w U 50gm D474

14.3 Anti-inflammatory and antipruritic medicines

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Betamethasone Ointment/Cream 0.1% (as vale rate) P 15gm tube D73
Hydrocortisone Acetate Ointment or Cream 1% (as vale rate) P 15gm tube D262
Clotrimazole Betamethasone Cream 5 gm P 5gmtube D590
+ Neomycine Sulphate

14.4 Medicine affecting Skin Differentitation and Proliferation


Benzoyl Peroxide Lotion or Cream 5% S 20gm D68
Gel 2.50% 20gm D69
Salicylic Acid Topical Solution 5% P D468
Podophyllum Resin Cutaneous Solution 102% S D416

14.5 Scabicides and pediculicides

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ivermectin Tablet (Scored) 6mg T 1 tab x 10 D296
Permethrin Cream 5% P 30g D714
Lotion 1% U 50ml D715
Fusidic Acid Cream 2% P 10g D645

15. DIAGNOSTIC AGENTS (enlisted in section of Surgical and suture list)


16. PERITONEAL DIALYSIS SOLUTION restricted to tertiary care center where peritoneal dialysis is undertaken
17. DISINFECTANTS AND ANTISEPTICS
17.1 Antiseptics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Chlorhexidine Solution 5% ( Digluconate) P 100ml bottle D111
for dilution
Ethanol (Spirit) Cutaneous Solution 70% (denatured) P 100ml bottle D206
Povidone Iodine Solution 10% P 100ml / 500ml / 1litre D421
5% U 100ml / 500ml / 1litre D422
Hydrogen Peroxide Solution 6%w/v P 1litre D264
Surgical Spirit Solution 94% P 100ml / 500ml bolttle D494
17.2 Disinfectants
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Sodium Hypochlorite Powder for Solution 0.10% P D480
Glutaraldehyde Aqueous Solution 2.00% S 5 litre can D247
18. DIURETICS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Furosemide Tablet 20mg P 10 x 10 D238
40mg 10 x 10 D239
Oral Solution 20mg/5ml D240
Injection 10 mg/ml 2ml ampoule D241
Hydrochlorothiazide Tablet 50 mg P 10 x 10 D260
Spironolactone Tablet 25 mg S 10 x 10 D482
Spironolactone Tablet
100mg T 10 x 10 D483
Acetazolamide Tablet 250 mg S 10 x 10 D1
Torsemide Tablet 5mg S 10x10 D751
10mg 10x10 D752
mannitol IV 100ml T ND6
Triamterene Tablet 25mg T(R) ND28
Chlorthalidone Tablet 12.5mg T(R) ND24
19. EAR, NOSE AND THROAT PREPARATIONS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Xylometazoline Nasal Drop 0.05% Not in T(R) 10ml D535
children less than 3
month
Tetracaine Hydrochloride Solution 0.50% T D500
Cinnarizine Tablet 25mg T 10 x 10 D121
Hydrogen Peroxide Solution P D264
Chlorhexidine Solution 5% ( Digluconate) P 10ml D111
for Dilution
Ciprofloxacin Hydrochoride Solution (Eye /Ear Drop) 0.3% w/v Sterile P 5ml D125
Aqueous S
Ointment (Eye/Ear) 0.30% 5gm tube D126
Gentamicin Sulphate Solution (Eye/ Ear Drop) 0.30% P 5ml D244

Sodium bi Carbonate Ear Drop 8% P 5ml D477


Glycerine (Soda Bocarb
Glycerine)
Neomycin with hydrocortisone Ear Drops 5ml P 5ml D700

Sodium Chloride Nasal Drop 0.60% P 5ml D733


Glucose glycerine Nasal drop S ND2
ichthammol glycerin Ointment S ND3
Mometasone nasal spray T(R) ND18
Betahistine Tablet 8mg T(R) ND22
20. GASTROINTESTINAL MEDICINES
20.1 Antacids and other anti ulcer medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Aluminium Hydroxide+ Chewable Tablet 500mg U 10 x 10 D17
Magnesium Hydroxide + Active (250mg+250mg
Dimethicon/Simethicon +50mg)

Gel 250mg+250mg+50m 60ml D18


g/5ml

Ranitidine Tablet 150 mg P 10 x 10 D452


Injection 50mg/ 2ml S 2ml ampoule D453
Omeprazole Capsule 20mg P 10 x 10 D382
Pantoprozole Injection 40mg S Vial D400
Sucralfate Syrup 100ml S 10ml D738
ursodeoxycholic acid Tablet 300mg T(R) ND30
20.2 Antiemetic medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Metoclopramide Tablet 10 mg S 10 x 10 D339
Hydrochloride
Injection 5 mg/ml 2ml ampoule D340

Domperidone Tablet 10mg P 10 x 10 D188


Syrup 1mg/ml 30ml D189
Promethazine Tablet 10mg P 10x10 D721
Injection 25 mg/ml in 2-ml P 2ml ampoule D438
ampoule
Prochlorperazine Tablet 5 mg P 10 x 10 D435
25mg 10 x 10 D436
Ondansetron Injection 2mg/ml S 2ml / 4ml ampoule D384
Syrup 2mg/5ml 30ml D385
Tablet 4mg P 10x10 D706
Doxylamine Succinate Tablet 100mg T 10 x 10 D193
Granisetron IP Injection 3mg T(R) Ampoule D657
Tablet 1mg 10x10 D656
20.3 Anti-inflammatory medicines

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydrocortisone Acetate Suppository; Retention 25 mg S D263
Enema
Sulphasalazine Tablet 500 mg S 10 x 10 D493
20.4 Antispasmodic medicines

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Dicyclomine Hydrochloride Tablet 10mg P 10 x 10 D172
Injection 10mg/ml 2ml ampoule D173
Hyosine Butyl Bromide Tablet 10mg P 10 x 10 D269
suppository 20mg/ml D270
Drotavarine Injection 20mg/ml S 2ml D618
Tablet 40mg 10x10 D619
20.5 Laxatives
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bisacodyl Tablet 5mg P 10 x 10 D78
Suppository 10mg S 1x5 pkt D570
Lactulose Syrup 667mg/ml S 60ml D550
Glycerine Sodium Chloride Enema 15 % w/v 30ml, P 20mlplasticampoule D652

15 %w/v50ml 20mlplasticampoule D653

20.6 Medicines used in diarrhoea


Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
(Low osmolarity 1 sachet (200ml) D386
245mmol/l) 4.1
g/200ml;
Components to
reconstitute 200 ml
of Glucose-
electrolyte solution:
Glucose: 2.7 g;
Sodium Chloride:
0.52 g; Potassium
Chloride: 0.3g;
Trisodium Citrate
Dehydrate*: 0.58 g
Oral Rehydration Salts Powder Sachet U
20.5 g/l; 1 sachet (1litre) D387
Components to
reconstitute 1 litre of
Glucose-electrolyte
solution: Glucose:
13.5 g/L; Sodium
Chloride: 2.6 g/L;
Potassium Chloride:
1.5 g/L; Trisodium
Citrate dehydrate*:
2.9 g/L

Zinc Sulphate Dispersible Tablet (Scored) 20mg U 10 x 10 D541

20.7 Antihaemorrhoidal medicines Local anaesthetic, Astringent and Anti-inflammatory drug


Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Betamethasone Dipropionate Ointment 0.025%+0.1%+2.5% P 20gm tube D75
+ Phenylephrine + Lignocaine

Liquid Paraffin Liquid P 500ml bottle D315


Phenol Liquid S 1 litre/5 litre cane D406
Calcium Dobesilate Capsule 500 mg S 10x10 D576
Calcium Dobesilate+ Lignocain Ointment 0.25%+3 % S 30 g D577
2%

21. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES


21.1 Adrenal hormones and synthetic substitutes
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydrocortisone Sodium powder for Injection 100 mg P Vial D261
Succinate
Prednisolone Liquid 5mg/5ml P 120ml bottle D429
Methyl Prednisolone Injection 40mg/ml S 2ml ampoule D336
Methyl Prednisolone Injection 500mg S D336A
21.2 Contraceptives
21.2.1 Hormonal contraceptives
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ethinylestradiol + Tablet 30 micrograms + U 10 x 10 D209
Levonorgestrel 150 micrograms
Levonorgesterel Tablet 750mcg P 10 x 10 D303
Ethinylestradiol + Tablet 20mcg+ 150mcg T 1x21 D631
Desogesterol
30mcg+150mcg 1x21 D632

Ethinylestradiol+ Drospirenon Tablet 30mcg+3mg T 1x21 D633

Depot Medroxy progesteron Injection 150mg T Vial D604


acetate
Desogestrol Tablet 75mcg P 1x28 D605
21.2.2 Intrauterine devices
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Copper-containing device As per RCH Supply U D141
21.2.3 Barrier methods
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Condoms with or without As per NACO/ RCH supply U D138
Spermicide (Nonoxinol)
Diaphragms with Spermicide As per NACO/ RCH supply P D163
(Nonoxinol)

21.3 Estrogens
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Estradiol Valerate Tablet 2mg S 10 x 10 D207
Conjugated Equine Oestrogen Tablet 0.625mg T 10 x 10 D139

Estriol succinate Cream 15mg S Tube D628


21.4 Insulins and other antidiabetic agents
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Glibenclamide Tablet 2.5 mg P 10 x 10 D245
5 mg 10 x 10 D246
Insulin Injection (Soluble) Injection 40 IU/ml S 10 ml vial D276
100 IU/ml 10 ml vial D277
Intermediate-Acting Insulin (as Injection 40 IU/ml S 10 ml vial D278
Compound Insulin Zinc
suspension or Isophane
Insulin)
100 IU/ml 10 ml vial D279

Metformin Hydrochloride Tablet 500 mg P 10 x 10 D333


Glimipride Tablet 1mg T 10 x10 D545
2mg 10 x10 D546
Glipizide Tablet 2.5mg T 10 x10 D547
Tablet (Sustain released) 5mg 10 x10 D548

10mg 10 x10 D549

Premix Insulin 30:70 Injection 40IU/ml T Vial D720


Rapid Acting Insuline Injection 3ml/cart T Vial D728
Analogue
Biphasic Insuline Analogue Injection 3ml/cart T Vial D569
25:75
Gliptin Tablet 10x10 T 10x10 D651
vasopressin injection 2ml/vial T ND12
Pioglitazone Tablet 15mg T(R) ND19
Acarbose Tablet 50mg T(R) ND20
21.6 Progestogens
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Medroxy Progesterone Acetate Tablet 5mg S 10 x 10 D326

10mg 10 x 10 D327

Norethisterone Tablet 5mg S 10 x 10 D374


21.7 Thyroid hormones and antithyroid medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Levothyroxine Sodium Tablet 25mcg S 10 x 10 D304
50mcg 10 x 10 D305
100 mcg 10 x 10 D306
Potassium Iodide Tablet 60 mg S 10 x 10 D420
Propyl Thiouracil Tablet 50 mg S 10 x 10 D442
100 mg 10 x 10 D443
Iodine Solution 8mg/5ml S D280
Carbimazole Tablet 5mg S 10 x 10 D89
22. IMMUNOLOGICALS
22.1 Diagnostic agents
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tuberculin, Purified Protein Injection P D513
Derivative (PPD)
22.2 Sera and immunoglobulins
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Antitetanus Immunoglobulin Injection 500 IU S Vial D46
(Human)
Anti-D Immunoglobulin Injection 100 mcg S single dose prefilled D44
monoclonal (Thiomersal free) syringe/ Vial
300mcg single dose prefilled D45
syringe/ Vial
Polyvalent Snake Antivenom Injection 10ml P 10ml Vial D418
Serum
Diphtheria Antitoxin Injection 10 000 IU S Vial D184
Diphtheria Antitoxin Injection S
20 000 IU Vial D185
Rabies Immunoglobulin Injection 300 U/ml T 5 ml vial D725
Equine
22.3 Vaccines
22.3.1 For universal immunization (as per NRHM Supply)

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
BCG Vaccine Injection U Vial D65
Diphtheria,Pertussis and Injection U Vial D186
Tetanus combined (DPT)
vaccine
Hepatitis B Vaccine Injection 20mcg U 1ml Vial D257
Measles Vaccine Injection U Vial D323
Poliomyelitis Vaccine Oral Drop U D417
Tetanus Vaccine (Tetanus Injection U 5ml ampoule D499
Toxoid)
MMR (Live Vaccine) Injection P D357
22.3.2 For specific groups of individuals
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Anti rabies Vaccine Injection IM administration 2.5 IU S Vial D42
(Chickembryo)
Typhoid Vaccine Injection T Vial D759
Pneumococcal Injection T Vial D716
Hib vaccine Injection T Vial D658
23. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Neostigmine Metilsulfate Injection 500 micrograms S 1ml ampoule D361
2.5 mg 5ml ampoule D362
Suxamethonium Chloride Powder for Injection 50 mg/ml S Vial D495
(Succinylchloline)
Pancuronium Injection 2mg/ml T 10ml vial D394
Vecuronium Powder for Injection 20mg T Vial D519
Atracurium Injection 10mg/ml T 2.5ml ampoule D54
Tamsulosin Tablet 0.4mg T(R) a ND29
24. SPECIFIC MEDICINES FOR NEONATAL CARE
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Epinephrine Hydrochloride Injection 1 mg/ml P 1ml ampoule D199
(Adrenaline)
Atropine Sulphate Injection 0.6 mg/ml S 2ml ampoule D56
Sodium bi Carbonate Injectable Solution 1.4% Isotonic S D475
(Intravenous Fluid) (equivalent to Na+
167 mmol/l, HCO3-
167 mmol/l)
Calcium Gluconate Injection 100 mg/ml S 10ml ampoule D84
Dextrose Injectable Solution 10% Isotonic P 250ml/ 500ml D159
(Intravenous Fluid)
Salbutamol Sulphate Syrup 2 mg/5 ml P 100 ml D463
Respirator Solution for use 5 mg/ml 15ml D465
in Nebulizers
Sucrose Solution 24% T 10mlAmpoule D739
Surfactant porcine Injection 4ml/kg T(R) Vail D741
Caffein Citrate Injection 20mg/ml T 3mlvial D574
Syrup 20mg/ml 3ml vial D575
Indomethacin Injection 1mg T Vial D669
25. OPHTHALMOLOGICAL PREPARATIONS
25.1 Anti-infective agents

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Gentamicin Sulphate Solution (Eye/Ear drop) 0.30% P 5ml D244
Ciprofloxacin Hydrochoride Solution (Eye/Ear Drop) 0.3% w/v sterile P S 5ml D125
aqueous
Ointment (Eye/Ear) 0.30% 5gm Tube D126
Miconazole Solution (Eye Drop) 1% P 10ml D348
Povidone Iodine Ointment/ Drop 0.60% S D424
Acyclovir Ophthalmic Ointment 3.00% S 5gm tube D9
Ofloxacin Eye drops solution 0.30% P 5ml D551
Tobramycine Eye drops solution 0.30% P 5ml D552
Fluorescein Sodium Strip S D229
Tropicamide Eye Drops Solution 0.50% S 5ml drops D512
Moxifloxacin Eye drops solution 0.5%v/w S 5 ml vial D695
Fluconazole Eye drops solution 0.30% S 5 ml vial D636
Natamycin Eye drops solution 5% T 5 ml vial D697
25.2 Anti-inflammatory agents a

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Prednisolone Sodium Solution (Eye Drop) 0.50% S 5ml D430
Phosphate
1% 5ml D719
Dexamethasone Eye drops solution 0.10% S 5ml D606
Fluoromethalone acetate Eye drops solution 0.10% T 5ml D638
Ketorolac tromethamine Eye drops solution 1% S 5ml D677
Flurbiprofen Eye drops solution 0.03% S 5ml D641
25.3 Local anaesthetics see as per section 1.2
25.4 Miotics and antiglaucoma medicines

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acetazolamide Tablet 250 mg S 10 x 10 D1
Pilocarpine Hydrochloride or Solution (Eye Drop) 2.00% S 5ml D412
Nitrate
4.00% 5ml D413

Timolol Maleate Solution (Eye Drop) 0.25% S 5ml D505


0.50% 5ml D506
Brimonidine tatarate Eye drops solution 0.15% T 5ml D573
Dorzolamide Hydrochloride Eye drops solution 2% T 5ml D615

25.5 Mydriatics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Homatropine Solution (Eye Drop) 2% P 5ml D258
Phenylephrine Solution (Eye Drop) 4.00% P 5ml D407
Atropine Sulphate Solution (Eye Drop) 1.00% S 5ml D59
Eye ointment 1% P 3gm Tube D542
Tropicamide+Phenylephrine Eye drops solution 0.8%+5% T 5ml D758

Cyclopentolate Eye drops solution 2% S 5ml D594


26.6 Lubricating Agents
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Sodium corboxymethyl Eye drops solution 0.30% T 5ml D734
Cellulose
Hydroxyl propyl methyl Eye drops solution 0.30% T 5ml D660
Cellulose
Hyaluronidase Injection 75,000IU T 5ml D659
26. OXYTOCICS AND ANTIOXYTOCICS
26.1 Oxytocics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ergometrine Hydrogen Tablet 125 micrograms P 10 x 10 D200
Maleate
Injection 200 micrograms 1ml ampoule D201

Oxytocin Injection 10 IU P 1ml ampoule D393


Dinoprostone Gel 0.5mg T D183
Carboprost (PGF2) as Injection 0.25mg/ml T 1ml ampoule D91
Tromethamine USP (Preservative
Free)
Misoprostol Tablet 100mcg P 4tab x 10 D353
200mcg U 4tab x 10 D354
Mifepristone Tablet 200mg S 1tab x 10 D352
26.2 Antioxytocics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Isoxsuprine Injection 5mg/ml S 2ml ampoule D293
Isoxsuprine Hydrochloride Tablet 20 mg S 10 x 10 D294
40 mg 10 x 10 D295

27. PSYCHOTHERAPEUTIC MEDICINES


27.1 Medicines used in psychotic disorders
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Chlorpromazine Hydrochloride Tablet 100 mg T 10 x 10 D118

Syrup 25 mg/5ml D119

Injection 25 mg/ml 2ml ampoule D120

Fluphenazine Decanoate or Injection 25 mg S 1ml ampoule D231


Enantate
Haloperidol Tablet 1.5 mg S 10 x 10 D249
Tablet 5 mg 10 x 10 D250
Injection 5 mg 1ml ampoule D251
Liquid 2mg/ml 30ml D252
Olanzapine Tablet 5mg T 10 x 10 D380
10mg 10 x 10 D381
Injection 10mg 5ml D705
Risperidone Tablet 2mg T 10 x 10 D459
3mg 10 x 10 D460
Promethazine Hydrochloride Injection 25 mg/ml P 2ml ampoule D438

Lorazepam Tablet 1mg T 10 x 10 D318


Injection 4mg 10 x 10 D319
Amitriptyline Tablet 25mg T 10 x 10 D25
10mg 10 x 10 D25A
Sertraline Tablet 50mg T 10 x 10 D470
Clozapine Tablet 100mg T 10 x 10 D137
50mg S 10x10 D593
Quetiapine Tablet 50mg T 10x10 D723
100mg 10x10 D724
Nortriptyline Tablet 25mg T ND14
27.2 Medicines used in mood disorders
27.2.1 Medicines used in depressive disorders

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Imipramine Hydrochloride Tablet 25 mg P 10 x 10 D275
Fluoxetine Hydrochloride (for Tablet 20mg T 10 x 10 D230
use above 8 years of age)

Mirtazepine Tablet 7.5mg T 10x10 D691


15mg 10x10 D692
Escitalopram Tablet 5mg T 10x10 D625
10mg 10x10 D626
20mg 10x10 D627
27.2.2 Medicines used in bipolar disorders
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Carbamazepine Tablet (Control Release) 200 mg S 10 x 10 D86

400 mg 10 x 10 D87

Lithium Carbonate Tablet 300 mg T 10 x 10 D316


Valproic Acid (Sodium Salt) Tablet (Control Release) 200mg S 10 x 10 D514

500mg 10 x 10 D515

27.3 Medicines used in generalized anxiety and sleep disorders

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Diazepam Tablet (Scored) 5 mg P 10 x 10 D165
Triclofos Syrup 500mg/5ml T 30 ml D757
Chlordiasopoxide Tablet 25mg S 10x10 D585
Clonazepam Tablet 0.5mg P 10x10 D588

28. MEDICINES ACTING ON THE RESPIRATORY TRACT


28.1 Antiasthmatic medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Aminophylline Injection 25 mg/ml P 10ml ampoule D22
Epinephrine Hydrochloride Injection 1 mg P 1ml ampoule D199
(Adrenaline)
Salbutamol Sulphate Tablet 2 mg P 10 x 10 D461
4 mg 10 x 10 D462
Syrup 2 mg/5 ml 100ml D463
Respirator Solution for use 5 mg/ml 15ml D465
in Nebulizers
MDI (CFC free) 100mcg/dose in 200 200 MDI D466
doses
Capsule (Rotacap) 200mcg 30 Cap D467
Terbutaline Tablet 2.5mg T 10 x 10 D497
Injection 0.5mg/ml 1ml ampoule D498
Etiophylline + Theophylline Tablet 77mg + 23mg P 10 x 10 D212
(100mg)
Theophylline Injection 25mg/ml P 2ml D212A
Ipratropium bromide Inhalation 20mcg/ S 200MDI D670
Formetrol+Fluticaxone Inhalation 5mcg+50mcg S 150MDI D643
Monteleukast Tablet 4mg S 10x10 D693
10mg 10x10 D694
28.2. Anti tussive and expectorants
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bromhexine Hydrochloride Syrup 4mg/5ml P 60ml D543
29. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
29.1 Oral
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
(Low osmolarity 1 sachet (200ml) D386
245mmol/l) 4.1
g/200ml;
Components to
reconstitute 200 ml
of Glucose-
electrolyte solution:
Glucose: 2.7 g;
Sodium Chloride:
0.52 g; Potassium
Chloride: 0.3g;
Trisodium Citrate
Dehydrate*: 0.58 g
Oral Rehydration Salts Powder Sachet U
20.5 g/l; 1 sachet (1litre) D387
Components to
reconstitute 1 litre of
Glucose-electrolyte
solution: Glucose:
13.5 g/L; Sodium
Chloride: 2.6 g/L;
Potassium Chloride:
1.5 g/L; Trisodium
Citrate Dehydrate*:
2.9 g/L

29.2 Parenteral
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Dextrose Injectable Solution 5% P 250ml/500ml D158
(Intravenous Fluid)
10% Isotonic 250ml/500ml D159

50% Hypertonic 250ml/500ml D160

5% Dextrose, 0.18% P 250ml/500ml D162


Sodium chloride
(equivalent to Na+
30 mmol/l, Cl- 30
mmol/l)

5% Dextrose, 0.9% 250ml/500ml D161


Sodium chloride

25% P 250ml/ 500ml D544

Potassium Chloride Injection 11.2% (equivalent to P 20 ml ampoule D419


K+ 1.5 mmol/ml, Cl-
1.5 mmol/ml)

Sodium Chloride Injectable Solution 0.45% Isotonic P 250ml/500ml D478


(Intravenous Fluid)
0.9% Isotonic 250ml/500ml D479
(equivalent to Na+
154 mmol/l, Cl- 154
mmol/l
Injection 20ml T Ampoule D732
Sodium bi Carbonate Injectable Solution 1.4% Isotonic P D475
(Intravenous Fluid) (equivalent to Na+
167 mmol/l, HCO3-
167 mmol/l)
Sodium Lactate, Compound Injectable Solution Each 100ml U 100ml/500ml D481
Solution (Ringer Lactate (Intravenous Fluid) contains: Sodium
Solution) Lactate 0.32gm,
Potassium Chloride
0.4gm, Sodium
Chloride 0.6gm,
calcium chloride
0.027gm.
Calcium Gluconate Injection 100 mg/ml in 10-ml S D84
ampoule
Injectable Solution Each 100ml P 100ml D194
(Intravenous Fluid) Contains: Anhydrous
Electrolyte G (Multi- Dextrose 5gm;
Electrolyte with 5% Sodium Chloride
Dextrose IV Injection Type 0.37gm; Potassium
III USP Chloride 0.13gm;
Ammonium Chloride
0.37gm; Sodium
Sulphite 15mg

Injectable Solution Each 100ml P 100ml D195


(Intravenous Fluid) Contains: Anhydrous
Electrolyte M (Multi- Dextrose 5 g;
Electrolyte with 5% Sodium Acetate
Dextrose IV Injection Type Trihydrate 0.28 g
III IP)
Potassium Chloride
0.15 g; Dibasic
Electrolyte
Potassium
Phosphate 0.13 g
Sodium Chloride
0.091 g
Injectable Solution Each 100ml P 100ml D196
(Intravenous Fluid) contains:
Electrolyte P (Multi-
Electrolyte with 5%
Dextrose IV Injection Type
I IP) Anhydrous Dextrose
5gm,
Potassium Chloride
0.13gm,
Sodium Acetate
0.32gm,
Dibasic Potassium
Phosphate 0.026gm,

Magnesium Chloride
0.031gm
29.3 Miscellaneous

Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Water for injection Injection P 2ml ampoule D532
5ml ampoule D533
10ml ampoule D534
sodium citrate Syrup 100ml S ND1
30. VITAMINS AND MINERALS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ascorbic Acid (Vit C) Tablet (Scored) 100 mg P 10 x 10 D51
Ascorbic Acid (Vit C) Tablet (Scored) 500 mg P 10 x 10 D51A
Iodine Solution 8mg/5ml S D280
Folic Acid Tablet 1mg S 10 x 10 D232
5mg 10 x 10 D233
Vitamin A Palmitate Tablet 50 000 IU P 10 x 10 D524
Oral Oily Solution 100 000 IU/ml U Multidose Dispenser D525
Thiamine Hydrochloride (Vit Injection 50mg S 10ml D502
B1)
Riboflavin (Vit B2) Tablet 5mg U 10 x 10 D455
Pyridoxine Hydrochloride (Vit Tablet 25 mg P 10 x 10 D447
B6)
Multivitamin (B1,B2,B6, Tablet/ Capsule 10mg + 10mg + 3mg P 10 x 10 D63
Niacinamide, Pantothenate, + 100mg + 50mg +
Folic Acid, Ascorbic Acid, 1.5mg + 150mg +
Biotin) 100mcg
Vitamin B12 (Cyanocobalamin) Injection 500mcg/ml S 5ml ampoule D526

Methylcobalamine Tablet 1500mcg S 10 x 10 D526A


Niacinamide Tablet 50mg U 10 x 10 D365
Vitamin D3 Granules 1gm S Sachet D527
Calcium Salts Tablet 500mg (as elemental U 10 x 10 D85
calcium)
Multivitamin + Multimineral Syrup P 100ml D696
Pyridoxine Hydrochloride Tablet 50mg P 10x10 D722
Vitamin D3 Drops 400IU T 30ml bottle D761
Zinc Acetate Syrup 20mg T 30ml bottle D763
Surgical Products
Surgical List Size Unit Pack Facility Code Code
Absorbable gelatine sponge IP 80mmX 50mmX10mm S C1
Absorbent Cotton Woll IP - 700 Gms Roll P C2

Adhesive Plasters USP/Spool Zinc Oxide 7.5cm X 5mts. Spool T C3


Self Adhesive Plaster USP
7.5cm X 10mts. 4 Rolls T C4
0.00 Nos S C5
0.0 Nos S C6
0 Nos S C7
Airways Guedi 1 Nos S C8
2 Nos S C9
3 Nos S C10
4 Nos S C11
Adult Nos P C12
AMBU Bag (Long lasting)
Pediatrics Nos P C13
Anesthesia Circuit S C14

Bleached Bandage Cloth Width: Counts


90cm, Length: 20mtrs,
Other Specifications As Per Schedule F(II) Meters P C15
40X40
of Drugs and Cosmetics Act 1940

Bleached Bandage Cloth Width: Counts


Other Specifications As Per Schedule F(II) Meters P C16
of Drugs and Cosmetics Act 1941

Bone Biopsy Needie Nos T C17


Bone Cement Nos T C18
Bone Narrow Aspiration Needle Nos T C19
Bone Narrow Biopsy Needle Nos T C20
Bone wax T C21
Catheters malecot's Rubber and Latx Nos T C22
Central Vein Catheters Nos T C23
Corrugated rubber/latex Nos T C24
10cm P C25
Crape Bandage
15cm P C26
16G Nos T C27
18G Nos S C28
20G Nos S C29
Disposable Needles 22G Nos P C30
23G Nos S C31
24G Nos S C32
26G Nos S C33
23g Nos S C34
Disposable Scalp Vein Set
24g Nos S C35
12 Nos S C36
Disposable Suction Catheter
14 Nos S C37
2cc Nos P C38
5cc Nos S C39
Disposable Syringes With Needle CGS 10cc Nos S C40
20cc Nos S C41
50cc Nos T C42
ECG papers 50mmX20mts S C43
10cm S C44
Elastoplast
15cm S C45
Endotracheal Connectors 2.5 - 10 mm Nos S C46
Endotracheal Tubes (Cuffed) 5.5 - 10 mm Nos S C47
Endotracheal Tubes (Uncuffed) 2.5 - 5 mm Nos S C48
16G Nos T C49
Epidural Set
18G Nos T C50
Adults Nos T C51
Flatus Tube
Pediatrics Nos T C52
16 Nos S C53
18 Nos S C54
Foley's Urinary Catheter Size
20 Nos S C55
22 Nos S C56
24 Nos S C56A
Gigglis Wire Saw S C57
6.1/2 Inches Pair P C58
6 Inches Pair S C59
Gloves
7.1/2 Inches Pair S C60
7 Inches Pair P C61
5 Nos S C62
6 Nos S C63
Infant feeding tubes
8 Nos S C64
10 Nos S C65
Infusion Pump Nos S C66
Adults Nos S C67
Inter costal drainage Tube (with Under
water seal)
Pediatrics Nos S C68
Adults Nos P C69
Intravenous Set with Airway and Needle
Pediatrics Nos P C70
14 Nos S C71
16 Nos S C72
18 Nos S C73
IV Cannula (Two Way) 20 Nos S C74
22 Nos S C75
24 Nos S C76
26 Nos S C77
Laminaria Tent - Medium Nos S C78
3 Nos T C79
Laryngeal Mask Airways
4 Nos T C80
Laryngoscopes Set of 4 Blades Nos S C81
Mackintosh Double Colour Water Proof Meters P C82
Mayo's cutting suture Needle Nos S C83
Medicated Sterile paraffin Gauze 10cmX10cm Nos S C84
Microdrip set 30 drops per ml Nos S C85
Multipara monitor (long lasting) Nos T C86
Needle Hypodermic - Insulin Needle 26G X 1/2 inch Nos S C87
Neonatal Resuscitation Kit Nos S C88
Neonatal Suction tube 10 french Nos S C89
Paper Adhesive Plaster; Micropore 10cm 1"X9.0mts Roll S C90
Paper Adhesive Plaster; Micropore 5cm 1"X9.0mts Roll S C91
Pediatric drip set 60 drop per ml Nos S C92
10cm X 2.7mts / Roll 10 Roll S C93
Plaster of Paris Bandages BP
15cm X 2.7mts / Roll 11 Roll S C94
Polypropyline MESH 15cm X 15cm T C95
Pulse oximeter T C96
Children : 10 Nos S C97

Ryle's Tube (P.V.C.)


Children : 12 Nos S C98
Ryle's Tube (P.V.C.) Adult : 16 Nos S C99
Adult : 18 Nos S C100
Adult : 20 Nos S C101
Adult Nos T C102
Sang's Taken Black More tube PVC
Pediatrics Nos T C103
Simple Plain Catheters Nos T C104
Skin grafting Blade Nos T C105
22G Nos S C106
23G Nos S C107
Spinal Needle
24G Nos S C108
25G Nos S C109
Stilletes All Size S C110
Suction Set Nos T C111
11 100 Blades / PacketS C112
15 100 Blades / PacketS C113
Surgical Blade
22 100 Blades / PacketP C114
23 100 Blades / PacketS C115
6 Nos/Pkt In
Size 11 - 15 S C116
Each Size
6 Nos/Pkt In
Size 1 - 5 S C117
Suture Needles Curved And Cutting Each Size
Assorted Pack 1/2 Circle Cutting 6 Nos/Pkt In
Size 16 - 20 S C118
Each Size
6 Nos/Pkt In
Size 6 - 10 P C119
Each Size
6 Nos/Pkt In
Size 11 - 15 S C120
Each Size
6 Nos/Pkt In
Size 1 - 5 S C121
Suture Needles Curved And Round Body Each Size
Assorted Pack 1/2 Circle RB 6 Nos/Pkt In
Size 16 - 20 S C122
Each Size
6 Nos/Pkt In
Size 6 - 10 S C123
Each Size
Tissue Biopsy Needle Nos T C124
Tourniquet PVC/Latex 5cm width Size Nos S C125

16 Nos S C126
Trochar and canula bivalve (Disposable
18 Nos S C127
and Metallic) (For SPC)

20 S C128

Tube Drain PVC Nos S C129

Universal Protection Kit (For Operation of


Nos C130
HIV +ve Patient; NACO)

Urinary Drainage Bag Nos P C131


Vaccum Drain Nos S C132
Diagnostic Agents
Name of Drug Formulation Strength / Size Facility Code Unit Packs Drug Code
Pregnancy Diagnostic Kit RCH Supply C160
Rapid Diagnostic Kit for malaria
NVBDCP Supply C161
(bivalent)
Bivalent RD Kit Test Kit S C139
NS1 Antigen C159
HB color scale for screening C140

Whole blood finger prick test for


C164
HIV screening in emergency

Uristix for albumine and sugar U C162


Viral transport Media Test Kit C163
Radio contrast media
(Please check whether facilities available at secondary level or not accordingly include)
Name of Drug Formulation Strength / Size Facility Code Unit Packs Drug Code
Oral Aqueous
Barium Sulfate 30 - 200% w/v S C133
Suspension
S 5ml ampoule C141
lohexol Injection 350 mg Iodine/ml S 10ml ampoule C142
S 20ml ampoule C143
Powder 3.5 kg C134
Enema 3.5 kg C135
Barium Sulphate HD 300gm 5x300GMS C136
Paste 200gm 5x300GMS C137
Rapid Transit 125gm 5x200GMS C138
300mg/40ml C146
300mg/50ml C147
350mg/20ml C148
350mg/50ml C149
Non Ionic Contrast Media 350mg/100ml C150
370mg/20ml C151
370mg/50ml C152
370mg/50ml C153
370mg/100ml C154
10ml Vial C144
MRI Contrast media
20ml Vial C145
320mg/50ml C155
Non Isosmolar lonic Contrast 320mg/100ml C156
Media 270mg/50ml C157
270mg/100ml C158
Suture List
1. Absorbable Sutures.
1.1 Catgut Chromic (With needle)
Surgical List Size Unit Pack Facility Code Code
Chromic with CD RB needle 40mm
1/0 12 Foils T S27
Length 75cm
Chromic with 1/2 Cir RB needle
3/0 12 Foils T S22
20mm Length 75cm
Chromic with 1/2 Cir RB needle
2 12 Foils T S21
30mm Length 75cm
Chromic with 1/2 Cir RB needle
2/0 12 Foils T S23
40mm Length 75cm
Chromic with ST RB needle 60mm
1 12 Foils T S29
Length 75cm
Chromic with CD cutting needle
3/0 12 Foils T S25
12mm Length 70cm
Chromic with Cir RB needle 40mm
2/0 12 Foils T S28
Length 75cm
Chromic with CD RB needle 30mm
3/0 12 Foils T S26
Length 75cm
Chromic with CD cut needle 26mm
3/0 12 Foils T S24
Length 75cm
Suture List
1. Absorbable Sutures.
1.2 Chromic (Without needle)
Surgical List Size Unit Pack Facility Code Code
2/0 12 Foils T S11
1/0 12 Foils T S12
1 12 Foils T S13
Catgut Chromic length 150cm
2 12 Foils T S14
3/0 12 Foils T S15
3 12 Foils T S86
Suture List
1. Absorbable Sutures.
1.3 Catgut Plain (Without needles)
Surgical List Size Unit Pack Facility Code Code
2/0 12 Foils T S16
1/0 12 Foils T S17
1 12 Foils T S18
Catgut Plain 150cm
2 12 Foils T S19
3/0 12 Foils T S20
3/0 12 Foils T S87
Suture List
1. Absorbable Sutures.
1.4 Synthetic absorbable sutures
Surgical List Size Unit Pack Facility Code Code

3/0 12 Foils T S71


Synthetic absorbable sutures with 1/2 CIR
2/0 12 Foils T S72
RB needles 20mm length 70cm

4/0 12 Foils T S73

Synthetic absorbable sutures with 1/2 CIR


1/0 12 Foils T S74
RB needles 30mm length 90cm
Synthetic absorbable sutures with 1/2 CIR T
1 12 Foils T S78
cut needles (H) 40mm length 90cm
Synthetic absorbable sutures with 1/2 CIR
3/0 12 Foils T S75
RB needles 40mm length 90cm
Synthetic absorbable sutures with 1/2 CIR
3/0 12 Foils T S70
cutting needles 36mm length 70cm

2/0 12 Foils T S76


Synthetic absorbable sutures with 1/2 CIR
RB needles 40mm length 90cm
1/0 12 Foils T S77

Synthetic absorbable sutures with CD


3/0 12 Foils T S81
cutting needles 22mm length 45cm
Synthetic absorbable sutures with SP MP
6/0 12 Foils T S83
DOUBLE needles 8mm length 45cm
Synthetic absorbable sutures with 3/8 CIR
4/0 12 Foils T S80
cutting needles 16mm length 45cm
Synthetic absorbable sutures with 3/8 CIR
5/0 12 Foils T S79
cutting needles 16mm length 45cm
Synthetic absorbable sutures with curved
5/0 12 Foils T S82
reverse cutting needles 12mm length 45cm
1 12 Foils T S88
1/0 12 Foils T S89
Poly Glactin
2/0 12 Foils T S90
3/0 12 Foils T S91
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.1 BLACK BRAIDED SILK (WITH NEEDLE)
Surgical List Size Unit Pack Facility Code Code
2/0 6 Reels T S1

3/0 6 Reels T S2
B.B. silk with 3/8 Cir CD with cutting
needle 45mm length 76cm
8/0 6 Reels T S84

10/0 6 Reels T S85


Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.2 BLACK BRAIDED SILK
2.2.1 BLACK BRAIDED SILK (WITHOUT NEEDLE IN REELS)
Surgical List Size Unit Pack Facility Code Code
1 6 Reels P S7

2 6 Reels S S8
Black braided silk (without needle in reels)
2/0 6 Reels S S9

3/0 6 Reels S S10


Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.2 BLACK BRAIDED SILK
2.2.2 BLACK BRAIDED SILK (WITH NEEDLE IN REELS)
Surgical List Size Unit Pack Facility Code Code
1 12 Foils S S3
2 12 Foils S S4
Black braided silk (with needle)
2/0 12 Foils P S5
3/0 12 Foils S S6
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.3 POLYMIDE MONOFILAMENT (NYLON) POLYAMIDE FILAMENT WITH NEEDLE
Surgical List Size Unit Pack Facility Code Code
Polyamide black Monofilament length 38cm
8/0 12 Foils T S36
size

4/0 12 Foils T S38


Polyamide with CD cut needle 16mm length
70cm
3/0 12 Foils T S39

Polyamide with CD Reverse cut needle


5/0 12 Foils T S40
12mm length 70cm
Polyamide with 1/2 Cir RB needle 40mm
1/0 12 Foils T S37
length 100cm
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.4 POLYPROPYLENE MONOFILAMENT STERILE PRECUTE LENGTHS
Surgical List Size Unit Pack Facility Code Code
1/0 12 Foils T S56
Polypropylene with 1/2 Cir RB needle
30mm length 70cm
2/0 12 Foils T S57

Polypropylene with 1/2 Cir RB needle


1 12 Foils T S58
40mm length 70cm

5/0 12 Foils T S53


Polypropylene with 1/2 Cir RB needle
16mm length 70cm
4/0 12 Foils T S54

Polypropylene with 1/2 Cir RB needle


3/0 12 Foils T S55
25mm length 70cm

3/0 12 Foils T S60


Polypropylene with 1/2 Cir Tapper cut DN
25mm length 90cm
2/0 12 Foils T S61

Polypropylene with CD cut RB D needle


4/0 12 Foils T S65
16mm length 60cm
Polypropylene with curved cut needle 22mm
3/0 12 Foils T S66
length 70cm

Polypropylene with 1/2 Cir RB heavy needle


1 12 Foils T S59
30mm length 70cm DN 25mm length 90cm

Polypropylene with cutting needle 45mm


1 12 Foils T S67
length 100cm
Polypropylene with 1/2 Cir CC double
4/0 12 Foils T S52
needle 13mm length 75cm
Polypropylene with 1/2 Cir Tapper cut
2/0 12 Foils T S62
double needle 17mm length 90cm
Polypropylene with 1/2 Cir Tapper cut
2/0 12 Foils T S64
needle 25mm length 90cm
Polypropylene with 1/2 Cir Tapper cut
3/0 12 Foils T S63
double needle 25mm length 90cm
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.5 POLYSTER BRAIDED COATED
Surgical List Size Unit Pack Facility Code Code
3/0 12 Foils T S30
Coated polyster Braided (1/2 Cir. RB needle
25mm length 75cm)
3/0 12 Foils T S31

Coated polyster Braided green with 1/2 circle


round body double needle 25mm suture length 3/0 12 Foils T S32
75cm
Coated polyster Braided with CD green D needle
17mm (Curved reverse cutting or curved round 2/0 12 Foils T S33
body or taper cut) length 90cm
Coated polyster Braided with CD white D needle
17mm (Curved reverse cutting or curved round 2/0 12 Foils T S34
body or taper cut) length 90cm
Coated polyster Braided with CD white D needle
25mm (Curved reverse cutting or curved round 2/0 12 Foils T S35
body or taper cut) length 90cm
Polybutylate Coated with Polyster Braided
(green) with 1/2 Circle tapercut V-5 17mm
2/0 12 Foils T S41
double armed needle, suture length of 90cm with
pledgets size 6X3X1.5cm
Polybutylate Coated with Polyster Braided
(green) with 1/2 Circle tapercut V-5 25mm
2/0 12 Foils T S42
double armed needle, suture length of 90cm with
pledgets size 6X3X1.5cm
Polyster Braided (green) 5 12 Foils T S68
Polyster Braided (green) 2 12 Foils T S69
Suture List
3. POLYGLECAPRON SUTURES
Surgical List Size Unit Pack Facility Code Code
Polyglecapron with 1/2 Cir Oval RB Contrast
3/0 12 Foils T S47
needle 26mm Length 70cm
Polyglecapron with 1/2 Cir Oval RB JB needle
2/0 12 Foils T S48
26mm Length 70cm

Polyglecapron with 3/8 cir cutting needle 25mm 3/0 12 Foils T S49

Polyglecapron with 3/8 cir reverse cutting needle


4/0 12 Foils T S50
16mm
Polyglecapron with curved reverse cutting needle
5/0 12 Foils T S51
16mm
Suture List
4. POLYDIOXANONE SUTURES
Surgical List Size Unit Pack Facility Code Code
Polydioxane with 1/2 Round body heavy needle
1 12 Foils T S43
40mm, length 90cm
Polydioxane with 1/2 Cir Reverse cutting
Orthopaedics Surgery (OS) needle 40mm, length 1 12 Foils T S44
90cm
Polydioxane with 1/2 Cir Round body needle
2/0 12 Foils T S45
30mm, length 70mm
Polydioxane with 1/2 Cir Round body needle
6/0 12 Foils T S46
11mm length 45cm
Format to Amend the Essential Drug List for Chhattisgarh

Please indicate the nature of submission by marking the appropriate bracket:

( ) Deletion of a listed drug (Please attach proven evidence of the harmful/


useless effects of the drug.)

( ) Addition of a new drug (Please attach evidence of the proven benefits of


this drug.)

( ) Replacement of a listed drug (Please attach evidence of the proven


benefits of such a replacement over the existing drug.)

Name of Drug (INN) / Generic

Dosage form and Strength

Therapeutic Class

Reason for Amendment

References

Advantages over existing drug(s)in the same therapeutic class

Supporting comparison of newly recommended drug(s) with similar drugs already


available under the specified category in respect of efficacy, safety, suitability and cost
effectiveness:
Drug Efficacy Safety Suitability Cost
Effectiveness

Proposed Drug

Drug available in
existing EDL

Efficacy: This column should summarise potential pharmacological actions duly


supported by data on pharmacodynamics and pharmakokinetics.

Safety: This column should summarise the possible side effects. If possible, the
incidence of frequent side effects and safety margins should be listed.

Suitability: Based on patient related conditions and contraindications. A convenient


dosage form or schedule which may have a strong impact on patient adherence to
treatment.

Cost Effectiveness: Total cost of the treatment rather than cost per unit should be the
guiding factor.

Submitted by :

Address:

Contact Person:

Telephone Number:

Signature: Date:
SUSPECTED ADVERSE DRUG REACTION REPORTING FORM
For VOLUNTARY reporting of Adverse Drug Reactions by healthcare professionals

INDIAN PHARMACOPOEIA COMMISSION (AMC/ NCC Use only)


(National Coordination Centre-Pharmacovigilance Programme of India) AMC Report No.
Ministry of Health & Family Welfare
Government of India
Sector-23, Raj Nagar, Ghaziabad-201002 Worldwide Unique
www.ipc.nic.in

A. PATIENT INFORMATION 12. Relevant tests / laboratory data with dates


1.Patient Initials 2. Age at time
of Event or 3. Sex M F
____________ date of birth
____________ 4. Weight _Kgs

B. SUSPECTED ADVERSE REACTION 13. Other relevant history including pre-existing medical
conditions (e.g. allergies, race, pregnancy, smoking, alcohol
5. Date of reaction started (dd/mm/yyyy)
use, hepatic/ renal dysfunction etc)
6. Date of recovery (dd/mm/yyyy)
7. Describe reaction or problem

14. Seriousness of the reaction


Death (dd/mm/yyyy) Congenital-anomaly
Life threatening Required intervention
Hospitalization/prolonged to prevent permanent
Disability impairment / damage
Other (specify) H

15. Outcomes
Fatal Recovering Unknown
Continuing Recovered Other (specify)
H
C. SUSPECTED MEDICATION(S)
S.No 8. Name Manufact Batch Exp. Date Dose Route Frequency Therapy dates (if known, Reason for use of
(brand and urer No./ Lot (if known)) used used give duration) prescribed for
/or generic (if known) No. Date Date
name) (if known) started stopped
i.
ii.
iii.
iv.
S.No 9. Reaction abated after drug stopped or dose 10. Reaction reappeared after reintroduction
As per C reduced
Yes No Unknown NA Reduced dose Yes No Unknown NA If reintroduced dose
i.
ii.
iii.
iv.
11. Concomitant medical product including self D. REPORTER (see confidentiality section on first page)
medication and herbal remedies with therapy dates 16. Name and Professional Address :_
(exclude those used to treat reaction)
Pin code: E-mail _________
Tel. No. (with STD code): _________
Occupation Signature _________________

17. Causality Assessment 18. Date of this report (dd/mm/yyyy)


ADVICE ABOUT REPORTING Suspected Adverse Drug
Report adverse experiences with medications Reaction
Report serious adverse reactions. A reaction is
Reporting Form
serious when the patient outcome is:
death For VOLUNTARY reporting
life-threatening (real risk of dying) of suspected adverse drug reactions by
hospitalization (initial or prolonged) health care professionals
disability (significant, persistent or permanent
congenital anomaly
required intervention to prevent permanent impairment
or damage

Report even if:


Youre not certain the product caused adverse reaction
You dont have all the details, however, point nos. 1, 5,
7, 8, 11, 15, 16 & 18 (see reverse) are essentially National Coordinating Centre
required. Pharmacovigilance Programme of India
Who can report: India Pharmacopoeia Commission
Ministry of Health & Family Welfare Government
Any health care professional (Doctors including of India
Dentists, Nurses and Pharmacists) Sector-23, Raj Nagar, Ghaziabad-201002
Tel.:0120-2783400, 2783401, 2783392, FAX:
Where to report: 0120-2783311
www.ipc.nic.in
Please return the completed form to the nearest Chhattisgarh : Pt. JNM Medical College,
Adverse drug reaction Monitoring Centre (AMC) or to Dr. Rajesh Hishikar hishikar@gmail.com
National Coordinating Centre 09424205700
A list of nationwide AMCs is available at:
http://ipc.nic.in and also at
http://cdsco.nic.in/pharmacovigilance.htm
Pharmacovigilance
What happens to the submitted information: Programme

Information provided in this form is handled in of


strict confidence. The causality assessment is
carried out at Adverse Drug Reaction Monitoring
India
Centres (AMCs) by using WHO-UMC scale. The for
analyzed forms are forwarded to the National
Coordinating Centre through the ADR database. Assuring Drug
Finally the data is analyzed and forwarded to the
Global Pharmacovigilance Database managed by
Safety
WHO Uppsala Monitoring Center in Sweden.

The reports are periodically reviewed by the


National Coordinating Centre (PvPI). The
information generated on the basis of these reports Confidentiality: The patients identity is held in
helps in continuous assessment of the benefit-risk strict confidence and protected to the fullest
ratio of medicines. extent. Programme staff is not ex-pected to
and will not disclose the reporters identity in
The information is submitted to the Steering response to a request from the public.
Submission of a report does not constitute an
Committee of PvPI constituted by the Ministry of admission that medical personnel or
Health and Family Welfare. The Committee is manufacturer or the product caused or
entrusted with the responsibility to review the data contributed to the reaction.
and suggest any interventions that may be required.
Essential Drug List-2016, Raipur, Chhattisgarh
List of Participants
No. Name Designation Institution/Organization
1 Dr. A.K. Chandrakar DME Raipur
2 Dr. S.P. Kujur Dean CIMS, Bilaspur
3 Dr. Shashank Gupta HOD, Medicine Pt. JNM Medical College, Raipur
4 Dr. G.P. Soni Prof. & HOD, SPM Pt. JNM Medical College, Raipur
5 Dr. Smt. Abha Singh HOD, Obs & Gyn Pt. JNM Medical College, Raipur
6 Dr. Prabir Chatterjee Executive Director SHRC, Raipur
7 Dr. S.A. Khan HOD (Pharmacology) CIMS, Bilaspur
8 Dr. Smt. S. Phuljhale HOD, Pediatrics Pt. JNM Medical College, Raipur
9 Dr. Pratibha Jain Shah HOD (Anesthesiology) Pt. JNM Medical College, Raipur
10 Dr. Rajesh Hishikar Professor (Pharmacology) Pt. JNM Medical College, Raipur
11 Dr. Nalini Mishra Professor (Obs & Gyne) Pt. JNM Medical College, Raipur
12 Dr. Lakhan Singh Professor (Medicine) CIMS, Bilaspur
13 Dr. S. Phuljhale MS, Orthopedics Pt. JNM Medical College, Raipur
13 Dr. K.S. Shandilya DD (Store), DHS Directorate of Health Services, C.G.
14 Dr. R. R. Sahani Joint Director Directorate of Health Services, C.G.
15 Dr. Rajesh Sharma SPO (Hosp. Ad.), Directorate of Health Services, C.G.
16 Dr. Prashant Sriwastava CMHO District - Durg
17 Dr. H. S. Uraon CMHO District - Raigarh
18 Dr. J P Meshram Civil Surgeon District Hospital, Durg
19 Dr. B.K. Das Civil Surgeon District Hospital, Raipur
20 Dr. P. Beck Associate Professor Pt. JNM Medical College, Raipur
21 Dr. R.K. Siddharth Associate Professor (Surgery) Pt. JNM Medical College, Raipur
22 Dr. Chandrashekhar Shrivastawa Associate Professor Pt. JNM Medical College, Raipur
23 Dr. Harshad Sakle Associate Professor Pt. JNM Medical College, Raipur
24 Dr. Rashmi Thakur Associate Professor Pt. JNM Medical College, Raipur
25 Dr. S. Sudha Associate Professor (Pediatrics) Pt. JNM Medical College, Raipur
26 Dr. V.B. Verma CIMS, Bilaspur
27 Dr. Rajkumar Agrawal General Manager CGMSC, Raipur
28 Mr. Fidius Kerketta Sr. Program Coordinator SHRC, Raipur
29 Mr. Narayan Tripathi Program Coordinator SHRC, Raipur
30 Arun Lal State Consultant Directorate of Health Services, C.G.

You might also like